ConductScience.org, home

Trial · NCT02571491

Comparison of the Efficacy of Ketamine in Pediatric Patients With Idiopathic Scoliosis After Surgery

NCT02571491, Phase 2, Completed, Fundació Sant Joan de Déu

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Comparison of the Efficacy of Ketamine in Pediatric Patients With Idiopathic Scoliosis After Surgery. Trials, record NCT02571491. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02571491

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Comparison of the Efficacy of Ketamine in Pediatric Patients With Idiopathic Scoliosis After Surgery
NCT number
NCT02571491
Status
Completed
Phases
Phase 2
Enrollment
48 participants, actual
Lead sponsor
Fundació Sant Joan de Déu
Conditions
Progressive Infantile Idiopathic Scoliosis
Interventions
Ketamine Hydrochloride, Placebo, Remifentanil, Morphine hydrochloride
First posted
2015-10-08
Last updated
2015-10-08
Other registries' IDs
eudract:2011-000407-41

Source ClinicalTrials.gov

Registered outcomes9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCumulative Consumption of Epidural Morphine at 72h Postoperativelyin the first 72 hours postoperatively
For the assessment of the related ketamine analgesic efficacy. Cumulative consumption of epidural morphine administered as loading dose, intraoperatively, of 0,3 mcg/kg/min until the surgery operation and 150mcg/Kg of Morphine hydrochloride 60min before extubation
SecondaryChange From Baseline in Pain Scores (Visual Analogue Scale)in the first 72 hours after surgery.Pain scores at rest and on cough using a 10cm Visual Analogue Scale(0=no pain, 10=worst possible pain for the analgesic efficacy assessment of the association of Ketamine and opiates
SecondaryRates of significant adverse eventsevery 4 hours from the begin until the end of the surgical operationTo assess the tolerability of the association of ketamine and opiates
SecondaryTime to oral tolerabilityup to 6 months from the end of the surgical operationTo assess the efficacy of the association of ketamine and opiates, measuring the time needed from the surgery for reaching the oral tolerability
SecondaryTime to First Postoperative Ambulationup to 6 months from the end of the surgical operationTo assess the efficacy of the association of ketamine and opiates, measuring the time needed to being able to walk without assistance within the room or outside the room
SecondaryTime to postoperative recoveryup to 6 months from the end of the surgical operationPost operation period needed for each patient from the end of the surgery until hospital discharge by counting each patient postoperative hospital night admissions
SecondaryChange From Baseline in Pain by sensorial test using the Voy Frey filamentin the first 72 hours post surgery
measure of the area of hyperalgesia of the inflamed skin and the length of the incision after 72 post surgery. The filaments is used to provide a range of forces to the skin of a test subject, in order to find the force at which the subject reacts because the sensation is painful.
SecondaryChange From Baseline in Pain Scores (Visual Analogue Scale)at week 6 and after 3 and 6 months post surgery.Assessment of pain at week 6 and chronic pain after 3 and 6 months post-surgery using the Visual Analogue Scale pain scale
SecondaryChange From Baseline in neuropathic pain using Douleur Neuropathique en 4 Questions (DN4) questionnaireat week 6 and after 3 and 6 months post surgery.
The (DN4) questionnaire is a screening tool for neuropathic pain consisting of interview questions (DN4-interview) and physical tests. Two questions (I and II) were based on the interview of the patient and two questions (III and IV) were based on a standardized clinical examination

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
10467917BACKGROUNDPubMed
10846153BACKGROUNDPubMed
12467992BACKGROUNDPubMed
14581110BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02571491

GET https://conductscience.org/api/trials/v1/NCT02571491/registered